ABBV - AbbVie - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABBV is currently covered by 17 analysts with an average price target of $262.38. This is a potential upside of $31.31 (-0.97%) from yesterday's end of day stock price of $264.96.

AbbVie's activity chart (see below) currently has 466 price targets and 366 ratings on display. The stock rating distribution of ABBV is 79.31% BUY and 20.69% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.9% with an average time for these price targets to be met of 416.38 days.

Highest price target for ABBV is $303, Lowest price target is $225, average price target is $262.38.

Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 20-Aug-2026. First documented stock forecast 31-Dec-2013.

Currently out of the existing stock ratings of ABBV, 46 are a BUY (79.31%), 12 are a HOLD (20.69%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Sep-2025

$303

$38.04 (14.36%)

$298

Buy Since 08-Dec-2021

$300

$35.04 (13.22%)

$295

Buy Since 23-Jan-2023

$260

$-4.96 (-1.87%)

$235

Buy Since 06-Feb-2020

$288

$23.04 (8.70%)

$261

Buy Since 23-Jan-2024

$285

$20.04 (7.56%)

$265

Show more analysts

Please expand the browser size to see the chart

What is ABBV (AbbVie) average time for price targets to be met?

On average it took 416.38 days on average for the stock forecasts to be realized with a an average price target met ratio 93.9

Which analyst has the current highest performing score on ABBV (AbbVie) with a proven track record?

JOHN BORIS

Which analyst has the most public recommendations on ABBV (AbbVie)?

John Boris has 2 price targets and 0 ratings on ABBV

Which analyst is the currently most bullish on ABBV (AbbVie)?

David Amsellem with highest potential upside - $44.65

Which analyst is the currently most reserved on ABBV (AbbVie)?

Jason Gerberry with lowest potential downside - -$120.94

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?